Lilly pens deal with Gateway Labs resident Amplitude for RNA vaccine platform for infectious disease

Eli Lilly has turned to one of its Gateway Labs residents to help the Big Pharma develop trans-amplifying RNA (taRNA) vaccines for infectious diseases.